- Home
- WRLD vs RLAY Comparison
WRLD vs RLAY Comparison
Compare WRLD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRLD
- RLAY
- Stock Information
- Founded
- WRLD 1962
- RLAY 2015
- Country
- WRLD United States
- RLAY United States
- Employees
- WRLD N/A
- RLAY N/A
- Industry
- WRLD Finance: Consumer Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRLD Finance
- RLAY Health Care
- Exchange
- WRLD Nasdaq
- RLAY Nasdaq
- Market Cap
- WRLD 859.5M
- RLAY 803.4M
- IPO Year
- WRLD 1991
- RLAY 2020
- Fundamental
- Price
- WRLD $175.30
- RLAY $5.58
- Analyst Decision
- WRLD
- RLAY Strong Buy
- Analyst Count
- WRLD 0
- RLAY 8
- Target Price
- WRLD N/A
- RLAY $17.25
- AVG Volume (30 Days)
- WRLD 44.4K
- RLAY 1.5M
- Earning Date
- WRLD 10-24-2025
- RLAY 11-05-2025
- Dividend Yield
- WRLD N/A
- RLAY N/A
- EPS Growth
- WRLD 10.95
- RLAY N/A
- EPS
- WRLD 14.92
- RLAY N/A
- Revenue
- WRLD $567,706,032.00
- RLAY $8,355,000.00
- Revenue This Year
- WRLD N/A
- RLAY $27.33
- Revenue Next Year
- WRLD $3.55
- RLAY $8.87
- P/E Ratio
- WRLD $11.95
- RLAY N/A
- Revenue Growth
- WRLD 0.80
- RLAY N/A
- 52 Week Low
- WRLD $104.99
- RLAY $1.78
- 52 Week High
- WRLD $185.48
- RLAY $7.07
- Technical
- Relative Strength Index (RSI)
- WRLD 53.78
- RLAY 75.79
- Support Level
- WRLD $165.96
- RLAY $5.17
- Resistance Level
- WRLD $179.60
- RLAY $5.72
- Average True Range (ATR)
- WRLD 5.42
- RLAY 0.28
- MACD
- WRLD -0.12
- RLAY 0.08
- Stochastic Oscillator
- WRLD 47.86
- RLAY 90.10
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).